For the first time in decades, the U.S. Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is growing harder to treat, and cases continue to climb nationwide.

The FDA announced Friday that it has approved zoliflodacin, sold under the name Nuzolvence, as a single-dose oral treatment for gonorrhea in the urogenital area in adults and adolescents 12 and older who weigh at least 77 pounds. The medication is administered as granules that dissolve in water. The nonprofit Global Antibiotic Research and Development Partnership collaborated with Innoviva Specialty Therapeutics Inc. to develop the drug.

And GSK announced Thursday that the FDA had approved its medication gepotidacin , with

See Full Page